(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-3.32%) $1.920
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
Live Chart Being Loaded With Signals
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, the United States, Asia, and internationally. It operates in two segments, Ophthalmic Devices and Microsurgery...
Stats | |
---|---|
Šios dienos apimtis | 852.00 |
Vidutinė apimtis | 934.00 |
Rinkos kapitalizacija | 9.60B |
EPS | $1.030 ( 2023-06-30 ) |
Last Dividend | $1.174 ( 2023-03-23 ) |
Next Dividend | $0 ( N/A ) |
P/E | 32.33 |
ATR14 | $0.276 (0.26%) |
Carl Zeiss Meditec AG Koreliacija
10 Labiausiai teigiamai susiję koreliacijos |
---|
10 Labiausiai neigiamai susiję koreliacijos |
---|
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
Carl Zeiss Meditec AG Finansinės ataskaitos
Annual | 2023 |
Pajamos: | $2.09B |
Bruto pelnas: | $1.21B (57.71 %) |
EPS: | $3.25 |
FY | 2023 |
Pajamos: | $2.09B |
Bruto pelnas: | $1.21B (57.71 %) |
EPS: | $3.25 |
FY | 2022 |
Pajamos: | $1.90B |
Bruto pelnas: | $1.13B (59.26 %) |
EPS: | $3.29 |
FY | 2021 |
Pajamos: | $1.65B |
Bruto pelnas: | $967.21M (58.73 %) |
EPS: | $2.64 |
Financial Reports:
No articles found.
Carl Zeiss Meditec AG Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$1.174 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.527 | 2013-03-01 |
Last Dividend | $1.174 | 2023-03-23 |
Next Dividend | $0 | N/A |
Payout Date | 2023-04-11 | |
Next Payout Date | N/A | |
# dividends | 11 | -- |
Total Paid Out | $7.38 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 1.86 | -- |
Div. Sustainability Score | 3.69 | |
Div.Growth Potential Score | 4.66 | |
Div. Directional Score | 4.17 | -- |
Year | Amount | Yield |
---|
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
PRNDY | Ex Dividend Knight | 2023-06-30 | Semi-Annually | 0 | 0.00% | |
EMSHF | Ex Dividend Knight | 2023-08-15 | Annually | 0 | 0.00% | |
UNCHF | Ex Dividend Knight | 2023-12-28 | Semi-Annually | 0 | 0.00% | |
KIROY | Ex Dividend Knight | 2023-08-17 | Semi-Annually | 0 | 0.00% | |
CCFN | Ex Dividend Knight | 2023-08-14 | Quarterly | 0 | 0.00% | |
SBGSY | Ex Dividend Knight | 2023-05-09 | Annually | 0 | 0.00% | |
FOJCY | Ex Dividend Junior | 2023-09-29 | Annually | 0 | 0.00% | |
AAGIY | Ex Dividend Knight | 2023-09-07 | Annually | 0 | 0.00% | |
WTKWY | Ex Dividend Knight | 2023-08-29 | Annually | 0 | 0.00% | |
MHGU | Ex Dividend Junior | 2023-09-14 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.132 | 1.500 | 7.36 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0 | 1.200 | 0 | 0 | [0 - 0.3] |
returnOnEquityTTM | 0.134 | 1.500 | 9.62 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 0 | 0.800 | -5.00 | -4.00 | [1 - 3] |
quickRatioTTM | 0 | 0.800 | -4.71 | -3.76 | [0.8 - 2.5] |
cashRatioTTM | 0 | 1.500 | -1.111 | -1.667 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | 24.02 | 1.000 | 2.22 | 2.22 | [3 - 30] |
operatingCashFlowPerShareTTM | 2.62 | 2.00 | 9.13 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 1.345 | 2.00 | 9.33 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.573 | 1.000 | 3.78 | 3.78 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.196 | 1.000 | 8.08 | 8.08 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 0 | 0.800 | -3.33 | -2.67 | [0.5 - 2] |
Total Score | 3.69 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 32.28 | 1.000 | 6.84 | 0 | [1 - 100] |
returnOnEquityTTM | 0.134 | 2.50 | 9.76 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 1.345 | 2.00 | 9.55 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 1.189 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 2.62 | 2.00 | 9.13 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | -28.41 | 1.500 | -10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.112 | 1.000 | 9.71 | 0 | [0.1 - 0.5] |
Total Score | 4.66 |
Carl Zeiss Meditec AG
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, the United States, Asia, and internationally. It operates in two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers products and solutions for the diagnosis and treatment of eye diseases; and systems and consumables for cataract, retinal, and refractive surgeries. It serves practicing ophthalmologists and optometrists, as well as physicians and surgeons in hospitals and outpatient surgery centers. The Microsurgery segment offers visualization solutions for invasive surgical treatments; and solutions in the area of ear, nose and throat, plastic and reconstructive, dental and spinal surgeries. It serves physicians in various fields and hospitals. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.